Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare progression-free survival of conventional paclitaxel
and carboplatin vs weekly paclitaxel and carboplatin in patients with newly diagnosed stage
II-IV ovarian epithelial, primary peritoneal, or fallopian tube cancer.